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Abstract
Fetal growth is critically dependent on energy metabolism in the placenta, which drives active exchange of nutrients.
Placental oxygen levels are therefore vital, and chronic hypoxia during pregnancy impairs fetal growth. Here we tested the
hypothesis that placental hypoxia alters mitochondrial electron transport chain (ETS) function, and sought to identify
underlying mechanisms. We cultured human placental cells under different oxygen concentrations. Mitochondrial
respiration was measured, alongside levels of ETS complexes. Additionally, we studied placentas from sea-level and high-
altitude pregnancies. After 4 d at 1% O2 (1.01 KPa), complex I-supported respiration was 57% and 37% lower, in
trophoblast-like JEG3 cells and fibroblasts, respectively, compared with controls cultured at 21% O2 (21.24 KPa); complex IV-
supported respiration was 22% and 30% lower. Correspondingly, complex I levels were 45% lower in placentas from high-
altitude pregnancies than those from sea-level pregnancies. Expression of HIF-responsive microRNA-210 was increased in
hypoxic fibroblasts and high-altitude placentas, whilst expression of its targets, iron-sulfur cluster scaffold (ISCU) and
cytochrome c oxidase assembly protein (COX10), decreased. Moreover, protein synthesis inhibition, a feature of the high-
altitude placenta, also suppressed ETS complex protein levels. Our results demonstrate that mitochondrial function is
altered in hypoxic human placentas, with specific suppression of complexes I and IV compromising energy metabolism and
potentially contributing to impaired fetal growth.
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Introduction
During the first trimester of pregnancy, the human fetus
develops in an environment characterised by a very low partial
pressure of oxygen (pO2) [1], which is strikingly close to that
experienced by mountaineers high on Mt Everest [2]. This
condition was termed Everest in utero, by Joseph Barcroft more
than 60 years ago, and is believed to favour organogenesis in the
embryo, and cell proliferation and angiogenesis in the placenta
[1].
At high altitude, where women are exposed to atmospheric
hypobaric hypoxia, the hypoxic nature of the uterine environment
is further exacerbated.Such chronic exposure to hypobaric
hypoxia during pregnancy leads to babies that are small for
gestational age [3], and an increased incidence of intrauterine
growth restriction and pre-eclampsia [4,5]. Curiously, normal
oxygen delivery to the fetus is maintained at altitudes of around
3000 m above sea-level despite a lower arterial partial pressure of
oxygen, at least in part due to increased erythropoiesis in both the
maternal and fetal circulations [6]. Somewhat paradoxically,
however, fetal oxygen consumption at high-altitude, when
corrected for body weight, is not different to that at sea level
[7], thus oxygen deprivation per se is not thought to be responsible
for the impairment in fetal growth. Instead, it has been proposed
that the high altitude placenta undergoes metabolic remodelling to
lower its own oxygen consumption, thereby maintaining oxygen
delivery to the fetus but at the cost of altered substrate delivery.
This concept has been extensively reviewed by ourselves and
others [8–9], yet the underlying mechanisms remain unresolved.
Placental dysfunction lies at the core of many common
complications of pregnancy, such as intrauterine growth restriction
and pre-eclampsia. These disorders can jeopardise the health of
both mother and fetus, accounting for ,60% of babies weighing
less than 1000 g that survive to only one year of life [10]. The
pathophysiology of pre-eclampsia is not completely understood,
but is thought to result from incomplete remodelling of the
maternal spiral arteries [11], disrupting the normal flow of blood
into the placenta and risking ischemia/reperfusion injury [1].
Indeed, the induction of oxidative stress is a component of pre-
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eclampsia [12], supported by reports of increased pro-oxidant
factors [13,14] and decreased anti-oxidant defences [14].
In this regard, placental mitochondria are likely to play a central
role in pre-eclampsia, being producers of reactive oxygen species
(ROS) at complexes I and III of the electron transport system
(ETS), and themselves targets of oxidative stress. Increased
superoxide production has been reported in pre-eclamptic
placentas [15], suggesting that the mitochondria are at increased
risk of oxidative damage. Indeed, in other metabolically-active
tissues, such as cardiac and skeletal muscle, oxidative stress is
associated with profoundly altered mitochondrial function [16,17].
For example, in hypoxic skeletal muscle, the downregulation of
ETS complexes I and IV may be an adaptive response to
respectively limit ROS production and oxygen consumption [18].
Additionally, recent data suggest that in early-onset pre-eclampsia
there is a high incidence of endoplasmic reticulum (ER) stress, a
phenomenon strongly associated with oxidative stress and which
shares a similar etiology [19].
Stabilization of hypoxia-inducible factor-1a (HIF-1a) under
hypoxic conditions leads to a downregulation of mitochondrial
oxygen consumption [20,21], and the HIF-responsive microRNA-
210 (miR-210) has been strongly implicated in this response
[22,23]. MiR-210 represses the iron-sulfur complex assembly
proteins (ISCU1/2) [23], which are required for the correct
assembly of iron-sulfur clusters in ETS complexes I, II and III. It
also represses the cytochrome c oxidase assembly protein (COX10)
[24], which is essential for assembly of ETS complexes I and IV.
HIF-mediated induction of miR-210 is, therefore, a potential
mechanism underlying placental remodelling in the oxidatively-
stressed high-altitude placenta, and is known to be elevated in
placental tissue derived from pre-eclamptic patients [25,26,27],
and in a recent study was shown to regulate trophoblast
mitochondrial respiration in pre-eclampsia [27]. An alternative
mechanism, however, may result from protein synthesis inhibition,
since there is marked evidence of ER stress resulting in protein
synthesis inhibition in high-altitude placentas [28], a feature
shared with the pre-eclamptic placenta [19]. Protein synthesis
inhibition might therefore restrict the synthesis of ETS complex
subunits, further repressing oxidative metabolism at the placenta.
In this study, we aimed to determine the effects of chronic
hypoxia on mitochondrial function in the human placenta and the
underlying mechanisms. We investigated mitochondrial respira-
tion and mRNA and protein expression of ETS complexes in two
placental cell types grown at different oxygen tensions; a human
trophoblast-like cell line and primary human placental fibroblasts.
Volumetrically, these cells represent the principal components of
the placenta, but may have different metabolic properties due to
their different functions. JEG3 cells possess many biological and
biochemical characteristics of syncytiotrophoblasts [29], they
produce placental hormones and express enzymes involved in
steroidogenesis. They have been widely used to examine the
hormonal function of trophoblast cells and intracellular receptor
mechanisms, and as a model in a great number of studies devoted
to the effects of endocrine-active compounds (xenoestrogens,
fitoestrogens, dioxins and pesticides) [29]. We also carried out
supporting experiments in cultures of the additional, trophoblast-
like BeWo cell line. Meanwhile fibroblasts, in addition to being the
most numerous cell type in the placenta, perform the functions of
stromal biosynthesis and structural support, and are therefore
essential to the growth of the villous trees, itself a metabolically-
demanding process.
Furthermore, we measured the expression of miR-210 and its
downstream targets, to determine whether they could be
implicated in a potential mechanism. Moreover, to investigate
whether protein synthesis inhibition suppresses mitochondrial
function, we studied the same placental cells when cultured at 21%
O2 in the presence of a non-lethal dose of salubrinal, a
phosphatase inhibitor which prevents dephosphorylation of
eukaryotic initiation factor 2 subunit a (eIF2a). Finally, we
extended our investigation into human placentas from high-
altitude pregnancies, comparing expression levels of mitochondrial
proteins, miR-210 and its targets with those in placentas from sea-
level pregnancies. We hypothesized that overlapping, cell-specific
mechanisms drive modifications of ETS activity in the hypoxic
placenta to suppress oxidative metabolism.
Materials and Methods
Ethics Statement
Informed, written consent for the use of placental samples to
research adaptations to hypoxia was obtained from subjects
recruited at St. Vincent’s General Hospital in Leadville, CO, USA
(3,100 m above sea-level) with the approval of the Colorado
Multiple Institutional Review Board (COMIRB Protocol 00–
623),and from subjects recruited at the University College
Hospital, London, UK (sea-level), with the approval of The
University College London Hospitals Committee on the Ethics of
Human Research (the Joint UCL/UCLH Ethics Committee, Ref
No: 03/0135).
Chemicals and Reagents
All chemicals and tissue culture reagents were purchased from
Sigma-Aldrich and Invitrogen Ltd (Paisley, UK) respectively,
except where otherwise mentioned. Salubrinal was purchased
from Chem-Bridge Corporation (San Diego, USA). The anti-Hu
Total OxPhos Complex primary antibody kit was purchased from
Invitrogen, anti-ISCU1/2 (FL-142) from Santa Cruz Biotechnol-
ogy (Insight Biotechnology, Wembley, UK), anti-COX10 from
Proteintech (Manchester, UK) and anti-citrate synthase from
Alpha Diagnostics (San Antonio, TX, USA).
Cell Cultures
Primary human placental fibroblasts were a gift from Professor
Ashley Moffett (University of Cambridge) and were isolated from
first and early second trimester placentas with Local Ethical
Committee approval [28]. These cells were grown in Dulbecco’s
Modified Eagle medium (DMEM), supplemented with 5% HI-
FBS, penicillin (100 U/ml), streptomycin (100 mg/ml), at 37uC in
a 5% carbon dioxide (CO2) atmosphere. JEG-3 cells were a gift
from Professor Ashley Moffett (University of Cambridge), and
were originally purchased from the American Type Culture
Collection and cultured according to their instructions (ATCC, cat
no. HTB-144 and HTB-36) [28,30]. JEG3 cells were grown in
RPMI 1640 medium supplemented with 5% heat-inactivated FBS
(HI-FBS), penicillin (100 U/ml), and streptomycin (100 mg/ml) at
37uC in a 5% CO2 atmosphere. The human choriocarcinoma cell
line BeWo cells were a gift from Dr. Stephen Charnock-Jones
(University of Cambridge) (ATCC, cat no. CCL-98). [28]. They
were cultured in DMEM/F12 medium supplemented with 10%
HI-FBS, penicillin (100 U/ml), streptomycin (100 mg/ml), at 37uC
in a 5% carbon dioxide (CO2) atmosphere.
For hypoxia experiments, placental fibroblasts, JEG3 cells and
BeWo cells were seeded at a low density with fresh media (RPMI
1640 medium, DMEM and DMEM/F12, respectively) in the
presence of HI-FBS, penicillin and streptomycin and were placed
directly into humidified hypoxic chambers (Ex Vivo system,
Biospherix Ltd, NY, USA) containing 1% O2 (1.01 KPa)/5%
CO2 balanced in nitrogen for 4 days. Control cells were incubated
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at 21% O2 (21.24 KPa)/5% CO2 or 10% O2 (10.11 KPa)/5%
CO2 under standard culture conditions. A concentration of 21%
O2 was chosen as a first control as this is the normal O2
concentration to which JEG3 and BeWo cells have adapted, whilst
10% O2 was used to mimic intraplacental conditions [1,10] at the
start of the second trimester in vivo. For hypoxic conditions, we
selected 1% O2 as this was shown to elicit a hypoxic response in
pilot studies. After 4 d, cells were harvested for analysis of
mitochondrial respiration, protein, mRNA and miRNA expression
levels or mitochondrial DNA (mtDNA) concentrations. After 4
days, hypoxia (1% O2) decreases the proliferation of JEG3 cells,
BeWo cells and placental fibroblasts by 40%, 60% and 18%,
respectively [28].
For protein synthesis inhibition experiments, placental fibro-
blasts and JEG3 cells were seeded at a low density with fresh
media as before. Untreated control cells and cells grown with a
sublethal dose of salubrinal (17.5 mM) were incubated at 21% O2/
5% CO2 for 3 d under standard conditions, and harvested for
analysis of protein levels. Inhibition of protein synthesis using these
cultured conditions was recently confirmed in a study published by
our group [28]. BeWo cells were seeded at a low density with fresh
media as before. Untreated control cells and cells grown with a
sublethal dosage of tunicamycin (2.5 ug/ml) or thapsigargin
(0.4 mM ) were incubated at 21% O2/5% CO2 for 3 d under
standard conditions, and harvested for analysis of ETS protein
levels.
Tissue Collection from Human Subjects
Exclusion criteria for subjects included renal disease, cardiac
disease, diabetes, chronic hypertension, pregnancy-induced
hypertension, pre-term delivery or any complication of preg-
nancy. Placentas (n = 6) were collected at sea level from elective
non-labored caesarean deliveries (two tissue samples from
different regions of each placenta), whilst 3 placentas (four
tissue samples from different regions of each placenta) was
collected at 3100 m altitude, again from elective non-labored
caesarean deliveries. Since the labor process is a strong inducer
of oxidative stress [31], only samples delivered by caesarean
section were used in this study. The samples were collected
immediately after delivery, by the same team at each site to
eliminate differences in tissue handling. Each placenta was
weighed and samples were taken using a systematic random
system by which each placenta was divided into five areas. Two
full-thickness samples were taken from each area. Samples were
washed in phosphate buffered saline (PBS) to remove blood,
snap-frozen in liquid nitrogen within 10 min of delivery and
stored at 280uC until further analysis.
Mitochondrial Respirometry
Mitochondrial respiration was measured in permeabilised cells,
as described previously [1,32]. Briefly, harvested cells were washed
with PBS and re-suspended in respiratory medium (0.5 mM
EGTA, 3 mM MgCl2.6H2O, 20 mM taurine, 10 mM KH2PO4,
20 mM HEPES, 1 mg/ml BSA, 60 mM potassium-lactobionate,
110 mM mannitol, 0.3 mM dithiothreitol, pH 7.1). Density of cell
suspensions was determined using a haemocytometer and 26106
cells were added to a final volume of 500 ml respiratory medium,
equilibrated to atmospheric O2, in a water-jacketed oxygen
electrode chamber at 37uC (Strathkelvin Instruments Ltd,
Glasgow, UK) and the chamber was sealed. Cell membranes
were selectively permeabilised with digitonin (50 mg/ml) for 5 min,
before mitochondrial respiration was measured.
A substrate/inhibitor titration was used to analyse ETS
complexes I, II and IV. Initially, 10 mM glutamate and 5 mM
malate were added to the chambers, and complex I-supported
state 2 respiration was recorded. State 3 respiration was
stimulated by the addition of 2 mM ADP. Next, complex I
was inhibited by the addition of 0.5 mM rotenone, before
10 mM succinate was added and complex II-supported state 3
respiration recorded. Electron transport was then inhibited at
complex III by addition of 5 mM antimycin. Complex IV-
supported state 3 respiration was stimulated by addition of
0.5 mM TMPD and 2 mM ascorbate. Between experiments,
oxygen electrode chambers were washed for at least 40 min
with 100% ethanol and then several times with water to remove
any trace of respiratory inhibitors.
Western Blotting
Cultured cells were harvested and washed with ice-cold PBS,
before being scraped into cell lysis buffer (20 mM Tris, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM
sodium pyrophosphate, 1 mM glycerolphosphate, 1 mM
Na3VO4, and complete mini protease inhibitor cocktail (Roche
Diagnostics, East Sussex, UK, pH 7.5), and transferred to a
microfuge tube. After pipetting up and down,30 times, cells were
kept on ice for 20 min with occasional vortexing and centrifuged
at 10,000 g for 5 min. Placental samples were homogenised in the
same lysis buffer as the cells using lysing matrix tubes (type D, MP
Biomedicals).
Bicinchoninic Acid (BCA) was used to determine protein
concentrations in the cultured cell and tissue lysates. Equal
amounts of protein were resolved using SDS-PAGE and
transferred to nitrocellulose membrane. Western blotting analysis
of protein expression was performed as described previously [33]
with Ponceau red staining used to normalize for protein-loading.
After incubation with primary and secondary antibodies, en-
hanced chemiluminescence (ECL) (GE Healthcare, Little Chal-
font, UK) and X-ray film (Kodak, Hempstead, UK) were used to
detect the bands. Band intensity was quantified by ImageJ (U.S.
National Institutes of Health, Bethesda, MD, USA).
DNA and RNA Extraction and Quantitative Real-time PCR
Analysis
DNA and RNA were extracted from cultured cells and human
placental samples using SIGMA GenEluteTM Mammalian Geno-
mic DNA Miniprep Kit and QIAGEN RNAeasy Mini kit,
respectively according to the manufacturer’s instructions. RNA
was further treated with TURBO DNase (Ambion) to eliminate
DNA contamination. A QIAGEN MiRNeasy Mini Kit was used
to extract miRNAs.
For total RNA analysis, cDNA was prepared using the first
strand synthesis kit from Fermentas. Real-time PCR was
performed using SYBR green Master Mix (Eurogentech) on ABI
PRISM 7500 Sequence Detection System. Samples were analysed
in triplicate and expression levels were normalised to the
housekeeping gene hypoxanthine guanine phosphoribosyl trans-
ferase (HPRT) or to HPRT and b-actin, together. Melting curve
analysis was performed to ensure specificity of PCR products. Fold
change was calculated using a standard curve method. Primer
sequences are available upon request.
For microRNA analysis, cDNA was prepared using RevertAid
H Minus Reverse Transcriptase (Fermentas) and microRNA
specific RT primers (TaqMan MiRNA assay). Real-time PCR of
miRNA targets was performed using TaqMan MicroRNA assays
(hsa-miR-210) according to manufacturer’s instructions and
normalised to a reference miRNA (RNU48). Fold change was
calculated using DDCt method.
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Real-time Quantitative PCR Analysis for Mitochondrial
DNA Content
Total DNA was extracted using QIAamp DNA Mini kit Q
(Qiagen, Milan, Italy). ABI Prism 7500 Sequence Detection
System was used for real-time quantitative polymerase chain
reaction (PCR) analysis using the Rnase P gene, as an endogenous
control and cytochrome b as mitochondrial target gene. Samples
were analysed in triplicate. The D cycle threshold (DCt) values
from each sample were obtained by subtracting the values for the
reference gene from the sample Ct, thus normalizing to nuclear
DNA.
Statistics
Results are expressed as means 6 SEM. All data were checked
for normal distribution. Analysis of variance (one way ANOVA)
with repeated measures and least significant difference (LSD) post
hoc independent unpaired t tests were used to determine differences
between groups in different oxygen environments for JEG3,
fibroblasts and BeWo cells (for respirometry, protein and DNA
levels). Independent t tests were used to determine differences
between placental samples from different altitudes and for JEG3
and fibroblasts mRNA quantification experiments. Data were
considered statistically significant at p,0.05.
Results
Mitochondrial Respiration Rates are Lower in Hypoxic
Placental Cells
To investigate whether mitochondrial function was altered in
hypoxic placental cells, we first compared respiration in primary
human placental fibroblasts cultured under 21% O2 and hypoxic
(1% O2) conditions. In order to study responses across a broad
spectrum of oxygen concentrations, we used three different
conditions: 1% O2, 10% O2 and 21% O2. All state 2 and state
3 rates were the same between 21% and 10% O2 culture
conditions indicating that these concentrations could be used as
our controls (Figure 1A). In hypoxic conditions, at 1% O2, state 2
respiration rates of fibroblasts were 56% lower compared with
those cultured at 21% O2 (56% of control rates; p,0.01) and 47%
lower compared to 10% O2 (Figure 1A). Complex I-supported
state 3 rates were 43% and 36% lower in fibroblasts cultured at
1% O2 compared with those cultured at 10% O2 (p,0.05) and
21% O2, respectively (Figure 1A), and there was no significant
difference in respiratory control ratios (RCRs; state 3/state 2)
between difference culture conditions, suggesting no alteration in
proton leak. Complex II-supported state 3 respiratory rates were
the same in fibroblasts cultured under all three oxygen conditions
(Figure 1A). However, complex IV-supported state 3 rates were
29% and 24% lower in fibroblasts cultured at 1% O2 (p,0.01)
compared with those cultured at 21% and 10% O2, respectively
(Figure 1A).
Primary trophoblast cells isolated from human placentas were
not suitable for these metabolic studies as they display molecular
evidence of ER stress (data not shown). This may account for the
fact that mitochondrial membrane potential declines progressively
in culture, to the point that it is almost totally lost at 96 h [34].
Over the same period there is activation of caspases 3 and 9, and
evidence of apoptotic cell death. Therefore, we analyzed a human
placental trophoblast-like cell line (JEG3) to determine whether
the hypoxia-induced mitochondrial respiratory rate changes we
observed in the placental fibroblasts were cell type-specific. As with
primary human placental fibroblasts, there were no differences in
all respiratory rates between cells cultured at 21% and 10%. In
JEG3 cells cultured at 1% O2, however, respiration rates were
33% lower compared with cells at 21% O2 (p,0.01), and 22%
lower than cells at 10% O2 (p,0.05) (Figure 1B). Complex I-
supported state 3 rates were 56% and 52% lower in JEG3 cells
cultured at 1% O2 compared with cells cultured at 21% O2
(p,0.05) and 10% O2 (p,0.05), respectively (Figure 1B) once
again, there was no significant difference in RCRs between
difference culture conditions, suggesting no alteration in proton
leak. Similar to our observation in fibroblasts, no differences were
apparent with respect to complex II-supported state 3 respiration
rates in JEG3 cells cultured under all three oxygen conditions
(Figure 1B). However, complex IV-supported state 3 respiration
rates were 22% and 23% lower in cells cultured at 1% O2
compared with cells cultured at 21% (p,0.001) and 10% O2,
respectively (p,0.001) (Figure 1B). Together, these data indicate a
strikingly similar response of lowered mitochondrial respiration
rates under severe hypoxia in two different placental cell types.
Supporting experiments were also performed on another chorio-
carcinoma cell line, BeWo cells, and demonstrated that hypoxia
impaired Complexes I–II and IV-supported state 3 rates (Figure
S1A).
Hypoxia Alters the Expression of Electron Transport
Chain Complexes in Placental Cells
Since the mitochondrial respiratory rates through complex I
were lowered in hypoxic conditions, we sought to determine
whether this was due to changes in the expression of components
that make up the ETS machinery. Decreased complex I-supported
rates can result from a decrease in mitochondrial membrane
potential, since many substrates for complex I rely on the proton
gradient for import. First, we used qRT-PCR to determine mRNA
expression levels of NDUFB8 (NADH dehydrogenase (ubiquinone)
1 beta subcomplex 8; encodes a complex I subunit), mtCOX2
(mitochondrially encoded cytochrome c oxidase II, also known as
MTCO2 or COX2; encodes a complex IV subunit) and ATP5a
(ATP-synthase 5a; encodes a complex V subunit) in both placental
fibroblast and JEG3 cells cultured in hypoxic conditions compared
to those cultured in normoxia. Transcript levels of NDUFB8 were
unchanged in both fibroblasts and JEG3 irrespective of O2
concentration (Figures 1C and 1D). However, mRNA expression
levels of mtCOX2 were 37% (p,0.05) and 44% (p=0.07) lower in
fibroblasts cultured at 1% O2 compared to fibroblasts at 10% O2
and 21% O2, respectively (Figure 1C). ATP5A (complex V) mRNA
expression was also significantly reduced in fibroblasts grown at
1% O2 compared to 21% O2 (49% of control; p,0.05) but again
did not change in JEG3. Whilst there were changes in mRNA
expression in fibroblasts, there were clearly none present in JEG3
cells.
Therefore, to determine whether a post-transcriptional mech-
anism was operating to regulate the protein subunits of the ETS
complexes I–IV (NDUFB8, subunit 30 KDa, subunit core2 and
mtCOX2, respectively) and V (ATP5a) in hypoxia, we used
western blot analysis to quantify the expression of these proteins.
Similar to respiratory rates, protein levels of all subunits tested
were unchanged in placental fibroblasts and JEG3 cultured at
21% O2 and 10% O2. Although protein levels of the complex I
subunit (NDUFB8) in fibroblasts at 1% O2 was 66% lower
compared to 21% O2 and 72% lower compared to 10% O2, these
values did not reach statistical significance (Figure 1E). Interest-
ingly, mtCOX2, the protein subunit of complex IV showed a 70%
decrease in expression in fibroblasts cultured at 1% O2 compared
with fibroblasts cultured at 21% O2 (p,0.05) and 10% O2
(p,0.05) (Figure 1E). This was consistent with a decrease in
mtCOX2 mRNA expression in these cells.
Hypoxia and Human Placental Mitochondria
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e55194
Similar to the fibroblast cells, levels of complex I subunit
NDUFB8 was, 64% and 55% lower in JEG3 cells cultured at 1%
O2 than in cells cultured at 21% (p,0.01) and 10% O2 (p,0.05),
respectively (Figure 1F). The concentration of the complex IV
protein subunit (mtCOX2) was also decreased, being 64% and
57% lower in JEG3 cells cultured at 1% O2 compared with cells
cultured at 21% (p,0.01) and 10% O2 (p,0.01), respectively
(Figure 1F). Since the mRNA expression of these genes was
unchanged (Figure 1D), the reduction in the levels of these
proteins likely reflects post-transcriptional regulation. Additionally,
protein levels of complex III subunit (sub core 2) were 27% and
26% lower in JEG3 cells cultured at 1% O2 than in control cells
cultured at 21% (p,0.05) and 10% O2 (p,0.05), respectively
(Figure 1F); while this trend was not significant in fibroblasts
(Figure 1E). Lastly, complex V subunit (ATP-synthase 5a) showed
26% lower levels of protein in JEG3 cells cultured at 1% O2
compared with cells at 21% O2 (p,0.05) but not different from
cells cultured at 10% O2 (Figure 1F). The complex II subunit (sub
30 KDa) concentration was not different in fibroblasts and JEG3
cells cultured under all conditions (Figures 1E and 1F). In contrast,
but in agreement with respirometry data, in BeWo cells, hypoxia
resulted in a downregulation of representative subunits of all five
mitochondrial complexes (Figure S1B). Altogether, these data
suggest that specific components of the ETS complexes are either
transcriptionally or post-transcriptionally regulated in response to
hypoxia and that this process may occur in a placental cell-type
specific manner. To exclude the possibility that a change in
mitochondrial content might underlie these observations, we
measured mitochondrial DNA content and citrate synthase levels
in both fibroblasts and JEG3 cells in all oxygen conditions and
found no significant differences (Figures 2A–D).
One method of post-transcriptional regulation involves miR-
NAs, which are 23 nucleotide RNAs that bind to complementary
sequences on mRNA transcripts and cause gene silencing by
translational repression or mRNA degradation [35]. Following our
finding that complex I and complex IV protein subunits were
decreased in both placental cell types in response to hypoxic
conditions, we investigated the expression of miRNA-210, a
known regulator of these complexes, along with the expression of
its targets COX10 (cytochrome c oxidase assembly protein; a
subunit of complex IV) and ISCU1/2 (iron-sulfur cluster scaffold
proteins), to determine whether the miRNA pathway might play a
Figure 1. Mitochondrial function and ETS mRNA and protein expression were altered in fibroblasts and JEG3 cells cultured in
hypoxic conditions. A, B) State 2 and state 3 respiration rates with the complex I substrates, glutamate and malate; and state 3 respiration rates
with the complex II substrate, succinate, and complex IV substrates, TMPD and ascorbate in A) fibroblasts and B) JEG3. C, D) Transcript levels of ETS
complexes I, IV and V (ATP-synthase) in C) fibroblasts and D) JEG3. E, F) Protein levels of ETS complexes I-IV and V (ATP-synthase) in E) fibroblasts
and F) JEG3. * p,0.05, ** p,0.01, *** p,0.001 compared with cells cultured at 21% O2; { p,0.05, {{ p,0.01, {{{ p,0.001 compared with cells
cultured at 10% O2. Three independent experiments were performed in duplicate for each condition; each experiment was carried out in duplicate.
doi:10.1371/journal.pone.0055194.g001
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Expression of microRNA-210 and its Targets is Altered in
Hypoxic Placental Fibroblasts
mechanistic role in this context. Remarkably, exposure of
placental fibroblasts to 1% O2 resulted in a substantial increase
in miR-210 levels, 12.8 and 9.7 fold greater than fibroblasts grown
at 21% O2 (p,0.001) and 10% O2 (p=0.001), respectively
(Figure 3A). This increase in miR-210 in hypoxic fibroblasts also
corresponded with a decrease in mRNA and protein levels of its
targets COX10 (p=0.07; 1% O2 vs. 10% O2) and ISCU1/2
(p,0.01; 1% O2 vs. both 10% O2 and 21% O2) (Figures 3C, 3E).
Alternatively, in JEG3 cells, there was no change in miR-210
expression under hypoxic conditions (Figure 3B). Yet, we
observed an increase in mRNA levels of both COX10
(p,0.01, 1% O2 vs. 21% O2; p,0.05, 1% O2 vs. 10% O2)
and ISCU1/2 (p,0.05, 1% O2 vs. both 10% O2 and 21% O2)
in hypoxic JEG3 cells (Figure 3D). Despite this increase in
mRNA expression, protein levels of COX10 and ISCU1/2 were
significantly lower in JEG3 cells exposed to 1% O2 compared to
those at 21% O2 (p,0.01 and p,0.05, respectively). These
values were also lower than in cells grown at 10% (p,0.05;
Figure 3F). Altogether, these findings suggest that different
placental cell types utilise distinct mechanisms to regulate
mitochondrial function: hypoxic fibroblasts initiate a miR-210-
based process whereas trophoblast-like JEG3 cells may use an
alternative mechanism.
Protein Synthesis Inhibition Results in Lower Levels of
ETS Proteins in Placental Cells
NDUFB8 transcript levels did not change (Figures 1C and
1D) however protein levels of NDUFB8 were over 60% lower
Figure 2. Citrate synthase protein levels and mitochondrial DNA copy number in placental fibroblasts and JEG3 cells. A, B) Protein
levels of citrate synthase in A) fibroblasts and in B) JEG3 cells. C, D) Mitochondrial DNA content in C) fibroblasts and D) JEG3. Minimum of four
biological replicates per cell type for each condition were performed.
doi:10.1371/journal.pone.0055194.g002
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in both cell types under hypoxia, indicating that other
mechanism(s) regulate the protein expression. To investigate
this further, we cultured primary placental fibroblasts and JEG3
cells in normoxia in the presence and absence of 17.5 mM
salubrinal, an inhibitor of the protein synthesis initiation factor
eIF2a. Salubrinal did not alter protein levels of representative
subunits from ETS complexes II (sub 30 KDa), III (sub core 2)
and V (ATP-synthase) in primary placental fibroblasts. Howev-
er, complex I (NDUFB8) and complex IV (mtCOX2) protein
expression was depressed by 88% (p= 0.06) and 71% (p,0.01),
respectively, in fibroblasts cultured with salubrinal relative to
those cultured without salubrinal (Figure 4A).
Interestingly, a more robust change was observed in JEG3 cells
cultured with salubrinal including a decrease in protein expression
of all ETS complexes assessed. Similar to placental fibroblasts,
protein levels of complexes I (NDUFB8) and IV (mtCOX2) were
97% and 75% lower in JEG3 cells than in controls (p,0.0001 and
p,0.001, respectively) (Figure 3B). However, analysis of complex-
es II (sub 30 KDa), III (sub core 2) and V (ATP5a) also revealed a
significant repression of protein expression in JEG3 cells compared
to controls by 31% (p,0.01), 80% (p,0.05) and 34% (p,0.01),
respectively (Figure 4B).
To further support the idea that there is a link between protein
synthesis inhibition and levels of the ETS complexes, we carried
Figure 3. MicroRNA-210 expression is induced in hypoxic fibroblasts but not in hypoxic JEG3 cells; RNA and protein expression of
COX10 and ISCU 1/2 are decreased in both fibroblasts and JEG3 cells cultured in hypoxic condition (1% O2). A, B) MiR-210 expression
in A) fibroblasts and in B) JEG3. C, D) Transcript levels of COX10 and ISCU1/2 in C) fibroblasts and D) JEG3. E, F) Protein levels of COX10 and ISCU1/
2 in E) fibroblasts and in F) JEG3. * p,0.05, ** p,0.01, *** p,0.001 compared with cells cultured at 21% O2; {p,0.05 compared with cells cultured
at 10% O2. Minimum of three biological replicates per cell type for each condition were performed.
doi:10.1371/journal.pone.0055194.g003
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out supporting experiments on BeWo cells using other inducers of
ER stress: tunicamicin and thapsigargin. Tunicamycin induces the
unfolded-protein response and thapsigargin elevates cytosolic Ca2+.
Both molecules therefore induce ER stress, via different mecha-
nisms, and in BeWo cells, both inhibitors altered protein levels of
representative subunits from ETS complexes (Figure S2A).
We also assessed whether salubrinal affected the expression of
COX10 and ISCU1/2 in fibroblasts and JEG3 cells. Salubrinal
treatment did not alter COX10 protein levels in fibroblasts
(Figure 4C), but levels were 55% lower in JEG3 cells (p,0.01)
(Figure 3D). Salubrinal decreased ISCU1/2 protein levels by 7%
in placental fibroblasts (p,0.05) and 30% in JEG3 cells (p,0.01)
(Figures 4C and 4D). Taken together, these data indicate that
protein synthesis inhibition alone can have similar effects to
hypoxia, in changing the expression of key proteins required for
ETS function. However, placental fibroblast cells appear to be
more resistant to the effects of salubrinal and hypoxia than
trophoblast-like cells.
High-altitude Pregnancy is Associated with Increased
Expression of miR-210
As our in vitro data suggests protein synthesis inhibition and
miR-210-driven mechanisms likely regulate mitochondrial
function in hypoxia, therefore we examined whether similar
effects occurred in vivo using placentas from high-altitude
pregnancies in which a high level of phosphorylation of eIF2a
has been recently identified [28]. Sea-level and high-altitude
placentas used in this investigation were matched for maternal age
and gestational age and were non-labored, caesarean deliveries.
Birth weights were 364 g lower at high altitude than at sea level,
and similar to other studies with a trend towards smaller placental
weights (Table 1).
There were no differences in mRNA transcript levels of
NDUFB8 (complex I), mtCOX2 (complex IV) and ATP5A (complex
V) in high-altitude placentas compared with sea-level controls as
revealed by qPCR analysis (Figure–5A). Despite this, protein levels
of NDUFB8 were 48% lower in high-altitude placentas than in
sea-level placentas (p,0.01). Furthermore, protein expression of
complexes II (sub 30 KDa), III (sub core 2) and IV (mtCOX2)
were lower in high-altitude placentas than in those from sea-level
pregnancies, by 36% (p,0.01), 28% (p,0.01) and 32% (p,0.05),
respectively. Protein levels of complex V (ATP5a) were, however,
unchanged (Figure 5B). These observations are reminiscent of the
changes seen in salubrinal-treated JEG3 cells suggesting that the
protein synthesis inhibition, previously reported in these placentas
[28] may be acting to suppress mitochondrial respiration.
Figure 4. Sublethal dosage of salubrinal downregulates ETS, COX10 and ISCU1/2 protein levels in fibroblasts and JEG3 cells. A, B)
Protein levels of ETS complexes I-IV and V (ATP-synthase) in A) fibroblasts and B) JEG3. C, D) Protein levels of COX10 and ISCU1/2 in C) fibroblasts
and in D) JEG3. * p, 0.05, ** p, 0.01, *** p, 0.001 compared with cells cultured without salubrinal. Minimum of three biological replicates per cell
type for each condition were performed.
doi:10.1371/journal.pone.0055194.g004
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The expression of miR-210 was 1.8-fold higher in placental
samples from high-altitude pregnancies compared to sea-level
placentas (p = 0.06; Figure 5D), whilst the mRNA expression of its
downstream target gene COX10 was 27% lower (p,0.01), and
COX10 protein expression was 30% lower (p,0.05) (Figure 5E
and 5F). No difference was observed in ISCU1/2 mRNA
expression between the two types of placentas assessed
(Figure 5E). However, protein expression of ISCU1/2 was 21%
lower (p= 0.06), (Figure 5F), suggesting that miR-210 is likely
involved in post-transcriptional repression of ISCU1/2. Overall,
these data point to overlapping mechanisms that modify the
translational regulation of ETS proteins in high altitude placentas
and in placental cells cultured under hypoxic conditions.
Discussion
In all metabolically-active tissues, sustained hypoxia necessitates
appropriate responses to maintain energetic and redox homeosta-
sis, and thereby supporting normal cellular function [16]. The
hypoxic placenta, however, faces the unique challenge of
sustaining sufficient oxygen transfer to the circulation of the
developing fetus whilst meeting the oxygen demands of its own
metabolism [9]. The consequences of a dysfunctional response
Table 1. Clinical characteristics of sea-level and high-altitude pregnancies; placental samples from non-labored, caesarean
deliveries were used for ETS complex protein, mRNA and microRNA analyses in this study.
Placentas from Non-Labored Caesarean Deliveries
Sea-Level (n = 6) High-Altitude (n =3)
Maternal Age (yrs) 31.562.1 34.061.0
Gestational Age (wks) 39.061.4 39.961.2
Birth Weight (g) 36276272 32636502
Placental Weight at Birth (g) 545644 530635
doi:10.1371/journal.pone.0055194.t001
Figure 5. Induction of miR-210, downregulation of ETS, COX10 and ISCU 1/2 protein levels of high-altitude human placentas. A)
Transcript levels of ETS complexes I, IV and V (ATP-synthase) and B) protein levels of ETS complexes I-IV and V (ATP-synthase). C) MiR-210 expression
in sea-level and high-altitude placentas. D) Transcript levels and E) protein levels of COX10 and ISCU1/2. F) Protein levels of citrate synthase.* p,0.05
compared with sea-level placentas. Placentas (n = 6) at sea level (two tissue samples from different regions of each placenta), and 3 placentas at
3100 m altitude (four tissue samples from different regions of each placenta) were performed. Each sample was carried out at least in duplicate.
doi:10.1371/journal.pone.0055194.g005
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could either result in fetal oxygen deprivation, if placental oxygen
consumption remained too high, or fetal nutrient deprivation, if
energetic impairment in the placenta limited the active transport
of substrates. A careful partitioning of oxygen between these
competing demands is therefore vital to prevent fetal growth
restriction and limit oxidative damage in placental and fetal
tissues.
We previously found that the high-altitude human placenta is
characterised by elevated levels of antioxidant molecules and a
lower ATP/ADP ratio, suggesting a diminished energy reserve
compared with the sea-level placenta [28]. We therefore
hypothesised that altered mitochondrial function plays a role in
the placental response to hypoxia and investigated the effects of
chronic hypoxia on mitochondrial energy metabolism in human
placental cells and the high-altitude placenta. We found a specific
decrease in the mitochondrial oxidative capacity of both JEG3
cells and fibroblasts in hypoxia with the ETS complex I substrates,
glutamate and malate. Conversely, respiration supported by the
complex II substrate, succinate, was unaffected by hypoxia.
Complex I protein levels were also lower in both hypoxic
fibroblasts and JEG3 cells; though notably transcript levels of
NDUF8, a subunit of complex I, were normal in all models,
suggesting that a post-translational mechanism underlies this
defect. Complex II protein levels were unaffected by hypoxia in
cultures, in agreement with normal respiratory rates with
succinate.
Complex I (NADH dehydrogenase) is one of the initial
complexes of the ETS, and accepts electrons from NADH to
reduce ubiquinone. It is, however, a source of the superoxide
anion [36], and the decreased activity we report here, which
corresponds with findings in hypoxic human skeletal muscle [18],
may represent a mechanism to protect mitochondria against
oxidative damage. Whilst the major mitochondrial source of ROS
in hypoxia is likely to be complex III rather than complex I [37], a
decrease in complex I activity could have the effect of suppressing
the entry of electrons into the ETS, decreasing ROS production at
Complex III [38]. Moreover, in hypoxic JEG3 cells, though not
fibroblasts, we also found decreased complex III protein levels. In
support of a protective, antioxidant role, we found that mtDNA
content was unchanged in both JEG3 cells and fibroblasts cultured
at different oxygen concentrations. MtDNA is known to decrease
in tissues such as muscle in response to acute oxidative stress and
this loss is exacerbated by chronic hypoxia [39]. Moreover, the
lack of changes in citrate synthase levels indicates an intrinsic
response within mitochondria as opposed to a decrease in
mitochondrial mass.
We also recorded decreased respiration rates with the complex
IV substrates TMPD and ascorbate in both cell types, suggesting
impaired electron transfer to the final acceptor, O2. Similarly,
protein levels of complex IV (cytochrome c oxidase) were
significantly decreased in both cultures at 1% O2. Curiously,
transcript levels of mtCOX2 (a subunit of complex IV) were
unaffected by hypoxia in JEG3 cells, but decreased in fibroblasts,
suggesting different regulatory mechanisms. A decreased complex
IV activity would serve to match the oxygen demands of placental
tissues to the diminished supply, suppressing oxidative metabolism
to protect against anoxia-induced cellular injury [40], but perhaps
also to allay the risk of fetal oxygen deprivation. Much is known
about the regulation of complex IV activity in hypoxic cells, with
hypoxia itself restricting O2 supply to the complex and HIF-
dependent upregulation of inducible nitric oxide synthase (iNOS)
generating nitric oxide (NO) [41]. NO competes with O2, thereby
reversibly inhibiting complex IV [42], and under sustained levels
of NO complex I is also inhibited [43].
Supporting a post-transcriptional regulatory mechanism, we
observed a strong upregulation of miR-210 in fibroblasts following
hypoxia, perhaps reinforcing the idea of mitochondrial suppres-
sion playing a protective role in hypoxia [23,44,45]. No such
changes were noted in JEG3 cells, however, though it has been
suggested that there are tissue-specific responses of miR-210 in
both transformed and primary cell types [46]. Curiously, whilst
miR-210 appears to be amongst the most robustly and consistently
upregulated micro-RNAs in hypoxia in some carcinoma cell lines
[24,46,47], it is downregulated in others [48]. Studies on BeWo
cells [47], found an induction of miR-210 after 24h and 48h of
incubation at 1% O2. Since JEG3 cells are metabolically very
active, it is possible that they induce miR-210 for a shorter time
period than placental fibroblasts, and this might account for the
variability seen after 4 d of hypoxic exposure. In support of this,
miR-210 was upregulated in isolated trophoblast cells after a short
exposure to hypoxia over 8h [27]. Based on these findings, we
examined ISCU1/2 and COX10 [24] in the two placental cell
types. As expected, we found a downregulation in mRNA and
protein levels of both COX10 and ISCU1/2 in placental
fibroblasts. In JEG3 cells, hypoxia led to higher transcriptional
levels of ISCU1/2 and COX10, but surprisingly the protein levels
were drastically lower despite the apparent absence of a miR-210
induction. While these results strengthen the direct correlation
between miR-210 and its targets in fibroblasts, an additional
mechanism is likely to be at play in JEG3 cells.
Recent published data from our colleagues [28] demonstrated
ER stress in high-altitude placental samples. When cultured under
the same conditions (1% O2) JEG3 cell proliferation rates were
decreased, but fibroblasts were not, Reinforcing the idea of cell-
type specific mechanisms, Yung et al. showed that hypoxia induced
higher levels of eIF2a phosphorylation in JEG3 cells than in
fibroblasts [28].
Given these observations, we assessed the effects of a protein
synthesis inhibitor (salubrinal) on the levels of ETS complexes and
of COX10 and ISCU1/2 in vitro. In fibroblasts, levels of both
complexes I and IV were lower, reminiscent of the changes in
hypoxia. Interestingly, COX10 levels remained unchanged with
only a mild reduction in ISCU1/2 levels supporting the idea that
miR-210 induction is responsible for these changes in hypoxia. In
JEG3 cells, levels of all ETS complexes, plus COX10 and ISCU1/
2 were lower than controls, similar to the trend in hypoxia and
highlighting protein synthesis inhibition as the major mechanism
operating in this cell type. Together, these data indicate that
overlapping mechanisms operate in tissue-specific manner in
hypoxia, ultimately compromising mitochondrial function, and
therefore cellular energetics.
Finally, we investigated whether features of the mechanisms
described in our in vitro models were present in placentas from
high-altitude. Here, we found significant upregulation of miR-210
in high-altitude placentas, which was similar to hypoxic placental
fibroblasts, though the increase was milder in comparison. This
may be due to the partial contribution of fibroblasts to the whole
human placenta, though fibroblasts do account for the largest
population of cells in a term placenta, or alternatively to a milder
degree of hypoxia in vivo compared to the 1% O2 culture used
here. This upregulation correlated with a loss of COX10 and
ISCU1/2. Correspondingly, levels of ETS complex subunits were
lower in the high-altitude placenta than at sea-level, though this
was not reflected in the mRNA levels of these subunits, suggesting
a post-translational repression. This may be due to miR-210
upregulation, or protein synthesis inhibition, which Yung et al.
[28] found to be present in the same placentas as were studied
here. The suppression of mitochondrial respiration in these tissues
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might necessitate an enhanced flux through glycolytic pathways,
and in agreement, we previously reported that these placentas had
lower levels of glucose alongside elevated lactate concentrations
[49].
The human placenta comprises a number of different tissues,
which are functionally, and perhaps metabolically, diverse. Thus it
is strength of this study that we have investigated the metabolic
response to hypoxia in two distinct placental cell types, as well as in
biopsies from human placentas that comprise a heterogeneous cell
mix. This study, and our previous metabolomics study of human
placentas from high altitude [49], ensures that our in vitro findings
are relevant to the in vivo situation. Moreover, placental metab-
olism remains a greatly understudied area when compared with
other tissues. Unfortunately, due to the damage caused to
mitochondrial membranes by freeze-thawing of tissue, we were
unable to measure respiration in the placental biopsies from high
altitude. A novel cryopreservation technique, recently developed
in our laboratory, that must be deployed at the time of collection
will allow these measures to be made in future studies [50]. It is
also worth noting that due to the logistical difficulties of collecting
these samples and the low number of deliveries at Leadville, the
number of healthy, non-labored placentas delivered by caesarean
section available to us for this study was low. We cannot, therefore,
exclude the possibility that we have made a type 2 error in our
analyses of ETS complex levels. Indeed, the birth weights of this
group were not significantly lower than in the sea-level controls,
yet in the larger group of subjects which included labored and
non-labored placental samples this did reach significance, in
agreement with other studies [3,51].
In conclusion, the human placenta responds to sustained
hypoxia by suppressing its own oxygen consumption at the
mitochondrial ETS. This might therefore sustain sufficient oxygen
transfer to the circulation of the developing fetus. The conse-
quences of this response, however, might underlie the low birth
weights of babies at altitude, either by compromising placental
energetics and hence transport function, or increasing placental
reliance on glycolytic ATP synthesis, resulting in fetal hypogly-
caemia, as has been suggested [7]. Similar mechanisms to those we
have reported, might underlie some common complications of
pregnancy, such as pre-eclampsia and IUGR, where hypoxia and
oxidative stress are features of the pathophysiology.
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